Back to Results

REMODEL - Renal mode of action of semaglutide in patients with type 2 diabetes and chronic kidney disease

Study category: Diabetes & Hormone Disorders

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Barbara Davis Center
Childrens Hospital Colorado
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Petter Bjornstad,  MD

Petter Bjornstad, MD

Study ID

Protocol Number: 21-2645

More information available at ClinicalTrials.gov: NCT04865770

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers